Contributions
Stay tuned—this is where the team’s scientific contributions will be shared.
Accolades
Check back soon to see how this team is being recognized.
Mechanisms linking exposures to PD risk remain unclear. Here, we will integrate quantitative epidemiological and metabolomic data with unique human stem-cell, alpha-synuclein (ɑS) biomarker and AI toolboxes. We will generate the first molecular and cellular “fingerprints” for PD-relevant pesticides, focusing on ɑS, membrane and inflammatory pathologies. Our study will also be the first to perform integrative analyses of three separate longitudinal PD cohorts (PEG, HBS, PPMI). Finally, our PD customized foundation AI model will shed light on whether and how specific pesticide exposures delineate new PD molecular and clinical subtypes with significant implications for targeted therapeutics.
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.